The company’s chairman and CEO, Peter Dornau, was recently interviewed by CEOLive.TV. During the interview, he talked about Ocean Bio-Chem’s achievements, the unique quality of its products, business strategy, and growth opportunities for the firm. The interview can be found on YouTube.
In the course of the interview, Dornau focused on the large growth opportunities the company has with its recently EPA-approved new product, ‘Xtrem-A-Cide P’. This product utilizes Ocean Bio-Chem’s patented technology to generate a chlorine dioxide solution which can applied as a deep-penetrating spray for easy application for surface elimination of MRSA, salmonella, H1V1, Hepatitus A, Herpes Simplex-2, Influenza-A, Rhinovirus Type 37, E-coli and other germs, viruses, and fungi.
Dornay explained there is a tremendous market for this new product. Possible users include housewives, schools, hospitals, cruise ships, hotels and other hospitality facilities, gyms and health clubs, sports arenas and stadiums, food processing operations, and rest rooms at businesses. For additional information about Ocean Bio-Chem, visit www.oceanbiochem.com.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
